Patrick Mauldin to United States
This is a "connection" page, showing publications Patrick Mauldin has written about United States.
Connection Strength
0.496
-
Estimating the Economic Burden of Acute Myocardial Infarction in the US: 12 Year National Data. Am J Med Sci. 2020 05; 359(5):257-265.
Score: 0.073
-
Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes. J Gen Intern Med. 2013 Feb; 28(2):208-15.
Score: 0.043
-
Design of the economic evaluation for the Interventional Management of Stroke (III) trial. Int J Stroke. 2008 May; 3(2):138-44.
Score: 0.032
-
Incidence and patterns of persistent opioid use in children following appendectomy. J Pediatr Surg. 2022 Dec; 57(12):912-919.
Score: 0.021
-
Surgical Outcomes Improvement and Health Inequity in a Regional Quality Collaborative. J Am Coll Surg. 2022 04 01; 234(4):607-614.
Score: 0.021
-
Medical costs and associated racial/ethnic and sex disparities in erythropoiesis-stimulating agent use: anemia management under the Medicare reimbursement policy. J Manag Care Spec Pharm. 2021 Aug; 27(8):1142-1152.
Score: 0.020
-
Association of High Burden of End-stage Kidney Disease With Decreased Kidney Transplant Rates With the Updated US Kidney Allocation Policy. JAMA Surg. 2021 07 01; 156(7):639-645.
Score: 0.020
-
Patterns of dispensed opioids after tonsillectomy in children and adolescents in South Carolina, United States, 2010-2017. Int J Pediatr Otorhinolaryngol. 2021 Apr; 143:110636.
Score: 0.019
-
Trends in Healthcare Expenditures Among US Adults With Hypertension: National Estimates, 2003-2014. J Am Heart Assoc. 2018 05 30; 7(11).
Score: 0.016
-
Renal Function Variability: An Independent Risk Factor for Graft Loss and Death following Kidney Transplantation. Am J Nephrol. 2018; 47(3):191-199.
Score: 0.016
-
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. Transplantation. 2017 12; 101(12):2931-2938.
Score: 0.016
-
Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III. J Am Heart Assoc. 2017 May 08; 6(5).
Score: 0.015
-
Better survival for African and Hispanic/Latino Americans after infrainguinal revascularization in the Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg. 2017 Apr; 65(4):1062-1073.
Score: 0.015
-
Referrals and the PCMH: how well do we know our neighborhood? Am J Manag Care. 2016 Nov; 22(11):721-725.
Score: 0.014
-
Predicting outcomes for infrapopliteal limb-threatening ischemia using the Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg. 2016 Jan; 63(1):114-24.e5.
Score: 0.013
-
Hospital resource utilization during coronary artery bypass surgery. J Interv Cardiol. 1994 Aug; 7(4):379-84.
Score: 0.012
-
Costs of pediatric stroke care in the United States: a systematic and contemporary review. Expert Rev Pharmacoecon Outcomes Res. 2014 Oct; 14(5):643-50.
Score: 0.012
-
The one-year attributable cost of post-stroke dysphagia. Dysphagia. 2014 Oct; 29(5):545-52.
Score: 0.012
-
Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke. 2014 Jun; 45(6):1791-8.
Score: 0.012
-
Psychosocial characteristics and pain burden of patients with suspected sphincter of Oddi dysfunction in the EPISOD multicenter trial. Am J Gastroenterol. 2014 Mar; 109(3):436-42.
Score: 0.012
-
Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients. Cancer. 2013 Apr 15; 119(8):1512-20.
Score: 0.011
-
Impact of diabetes control on mortality by race in a national cohort of veterans. Ann Epidemiol. 2013 Feb; 23(2):74-9.
Score: 0.011
-
Physician acceptance of academic detailing for schizophrenia among South Carolina Medicaid providers. J S C Med Assoc. 2012 Aug; 108(4):100-2.
Score: 0.011
-
The one-year attributable cost of poststroke aphasia. Stroke. 2012 May; 43(5):1429-31.
Score: 0.010
-
Two pharmacy interventions to improve refill persistence for chronic disease medications: a randomized, controlled trial. Med Care. 2009 Jan; 47(1):32-40.
Score: 0.008
-
Applying the resource-based relative value scale to the Emory angioplasty versus surgery trial. Am J Cardiol. 2000 Mar 15; 85(6):685-91.
Score: 0.005
-
The changing healthcare market and how it has influenced the treatment of cardiovascular disease--Part 1. Am J Manag Care. 1999 Sep; 5(9):1119-24.
Score: 0.004
-
The changing healthcare market: outlook for the future of cardiovascular disease treatment--Part 2. Am J Manag Care. 1999 Sep; 5(9):1125-30.
Score: 0.004
-
Cost-effectiveness analysis in the nursing literature, 1992-1996. Image J Nurs Sch. 1998; 30(3):235-42.
Score: 0.004
-
Economic winners and losers after introduction of an effective new therapy depend on the type of payment system. Am J Manag Care. 1997 May; 3(5):743-9.
Score: 0.004
-
Using physician work relative value units to profile surgical packages: methods and results for kidney transplant surgery. Best Pract Benchmarking Healthc. 1996 May-Jun; 1(3):140-6.
Score: 0.003
-
Access to and participation in breast cancer screening: a review of recent literature. Clin Perform Qual Health Care. 1996 Apr-Jun; 4(2):74-85.
Score: 0.003